Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The encoded protein degrades type IV collagen, fibronectin, fibrinogen, casein, vitronectin, alpha 1-antitrypsin, alpha 2-macroglobulin, and insulin-like growth factor-binding protein 1, and activates MMP9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain.
Liu, Cao, Li, Wu, Wang: "GnRH I and II up-regulate MMP-26 expression through the JNK pathway in human cytotrophoblasts." in: Reproductive biology and endocrinology : RB&E, Vol. 8, pp. 5, (2010) (PubMed).
de Amorim, da Silveira, Queiroz, Galvão, de Souza, de Almeida Freitas: "Matrilysins may not predict the metastatic potential in squamous cell carcinoma of the tongue." in: Acta odontologica Scandinavica, Vol. 68, Issue 4, pp. 228-31, (2010) (PubMed).
Park, Ni, Gerkema, Liu, Belozerov, Sang: "Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor." in: The Journal of biological chemistry, Vol. 275, Issue 27, pp. 20540-4, (2000) (PubMed).
de Coignac, Elson, Delneste, Magistrelli, Jeannin, Aubry, Berthier, Schmitt, Bonnefoy, Gauchat: "Cloning of MMP-26. A novel matrilysin-like proteinase." in: European journal of biochemistry / FEBS, Vol. 267, Issue 11, pp. 3323-9, (2000) (PubMed).
Uría, López-Otín: "Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity." in: Cancer research, Vol. 60, Issue 17, pp. 4745-51, (2000) (PubMed).